Skip to Content

Vadova Approval Status

  • FDA approved: No
  • Brand name: Vadova
  • Generic name: carbidopa and levodopa
  • Dosage form: Extended Release Tablets
  • Company: IMPAX Laboratories, Inc.
  • Treatment for: Parkinson's Disease

Vadova is an extended release formulation of carbidopa and levodopa under review for the treatment of Parkinson's disease. The FDA issued a non-approvable letter for Vadova in January 2008.

Development Status and FDA Approval Process for Vadova

Jan 30, 2008IMPAX Receives FDA Non-Approvable Letter for Vadova; Company Considering Options
Jan 18, 2007IMPAX Files Amendment to Vadova NDA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.